year
unit
state
babi
approxim
total
birth
born
full
week
gestat
grow
health
issu
rate
prematur
birth
increas
percent
sinc
earli
one
major
problem
associ
prematur
develop
condit
known
neonat
necrot
enterocol
nec
observ
clinic
abrupt
develop
bloodi
diarrhea
abdomin
swell
tender
prematur
infant
otherwis
well
current
treatment
often
requir
surgic
remov
damag
dead
intestin
often
result
mortal
infant
surviv
manifest
signific
result
lifetim
problem
although
direct
caus
nec
known
signific
contribut
factor
prematur
birth
postpartum
establish
abnorm
gut
microbiom
creat
opportun
bacteri
invas
gut
due
immatur
intracellular
junction
intestin
mucosa
experiment
clinic
evid
suggest
prematur
nec
associ
defici
endogen
product
epiderm
growth
factor
egf
necessari
normal
intestin
develop
repair
egf
critic
growth
factor
found
multipl
fluid
bath
develop
intestin
includ
amniot
fluid
fetal
urin
breast
milk
bile
saliva
amniot
fluid
increas
concentr
egf
gestat
progress
egf
amount
mother
milk
highest
first
day
parturit
mother
extrem
preterm
neonat
higher
mother
milk
full
term
infant
human
studi
demonstr
egf
resist
proteolyt
degrad
across
rang
gastric
ph
egf
produc
extent
duoden
brunner
gland
kidney
vast
major
egf
produc
salivari
gland
exogen
infus
egf
utero
shown
acceler
matur
intestin
enzym
activ
well
stimul
intestin
growth
import
egf
gut
develop
highlight
fact
knockout
egf
receptor
mice
strain
result
death
due
bloodi
diarrhea
remark
similar
human
nec
transgen
mice
direct
intestin
overexpress
egf
display
number
benefici
effect
includ
increas
bodi
weight
villu
height
small
bowel
resect
compar
nontransgen
mice
convers
inhibit
egf
receptor
impair
intestin
adapt
follow
small
bowel
resect
prospect
multicent
trial
demonstr
infant
fed
regular
formula
contain
growth
factor
time
like
develop
nec
infant
fed
breast
milk
larg
number
biolog
activ
peptid
growth
factor
identifi
breast
milk
egf
one
major
peptid
present
signific
concentr
concentr
egf
milk
found
invers
proport
gestat
age
infant
therefor
prematur
infant
egf
present
breast
milk
may
compensatori
respons
prematur
remov
fetu
egfrich
amniot
fluid
demonstr
sever
anim
model
nec
administr
exogen
egf
shown
significantli
reduc
sever
intestin
injuri
proactiv
treatment
infant
nec
risk
egf
supplement
could
therefor
acceler
intestin
matur
thu
prevent
develop
nec
proactiv
egf
feed
strategi
effect
induc
matur
neonat
intestin
tract
simpl
approach
may
mitig
develop
nec
result
high
cost
medic
resourc
pain
possibl
lifelong
debilit
infant
nec
prove
fatal
accomplish
proactiv
therapeut
approach
adapt
infant
formula
egf
deliveri
would
simpl
econom
mimic
deliveri
egf
mother
milk
need
potenti
deliveri
make
infant
formula
contain
egf
good
model
foodsourc
plant
biotechnolog
soybeanderiv
formula
encompass
signific
fraction
total
infant
formula
market
soybean
milk
deriv
product
potenti
foodtherapi
deliveri
platform
could
includ
varieti
medicallynecessari
product
includ
drug
egf
might
also
includ
oral
vaccin
economi
product
simpl
convers
therapeut
materi
longshelf
life
make
soybean
biotech
product
potenti
desir
commod
use
costsensit
scale
applic
address
devast
diseas
nec
simpl
proactiv
treatment
protocol
excel
platform
explor
potenti
soybeanproduc
therapeut
report
accumul
human
egf
hegf
geneticallyengin
soybean
seed
show
recombin
egf
indistinguish
authent
human
egf
bioactiv
stimul
egf
receptor
egfr
activ
epiderm
growth
factor
protein
human
produc
soybean
seed
construct
plant
gene
express
cassett
involv
synthet
codon
optim
egf
nucleotid
sequenc
protein
sequenc
genbank
access
bp
open
read
frame
place
infram
behind
acid
endoplasm
reticulum
er
signal
sequenc
arabidopsi
chitinas
gene
erdirect
egf
encod
open
read
frame
development
regul
strong
seedspecif
storag
protein
glycinin
regulatori
element
entir
seed
specif
cassett
direct
egf
product
place
vector
contain
hygromycin
resist
gene
strong
constitut
express
potato
ubiquitin
regulatori
element
previous
describ
result
plasmid
pgli
shegf
sequenc
use
glycinin
promot
primer
tcattcaccttcctctcttc
ensur
egf
open
read
frame
place
correctli
regulatori
element
somat
soybean
glycin
max
l
merril
cv
jack
wild
type
embryo
transform
via
biolist
use
mgl
hygromycin
b
select
regener
previous
describ
embryo
resist
line
analyz
genom
pcr
confirm
presenc
insert
hygromycin
cassett
use
primer
specif
hygromycin
gene
hygf
hygr
cetyl
trimethyl
ammonium
bromid
ctab
extract
genom
dna
isol
follow
amplif
condit
ng
genom
dna
total
reaction
contain
nm
primer
u
taq
polymeras
neb
follow
cycl
paramet
initi
min
cycl
follow
final
extens
min
dri
seed
two
success
gener
pcr
posit
plant
analyz
elisa
express
egf
protein
line
confirm
homozyg
egf
transgen
soybean
plant
along
nontransgen
control
wild
type
cultivar
plant
grown
side
side
greenhous
h
daylight
total
solubl
protein
extract
dri
seed
two
homozyg
egf
line
nontransgen
control
repeat
aceton
wash
follow
aceton
precipit
protein
pellet
dissolv
water
protein
molecular
weight
kda
isol
separ
pass
extract
amicon
ultra
centrifug
filter
merck
kenilworth
nj
sampl
suspend
sampl
buffer
tri
hcl
sd
wv
wv
bromphenol
blue
vv
glycerol
denatur
min
protein
content
determin
bradford
assay
sdspage
gel
use
separ
protein
three
sampl
neg
control
wild
type
line
egf
transgen
soybean
dri
seed
commerci
avail
human
egf
gibco
life
technolog
unit
kingdom
use
posit
control
gel
electroblot
onto
immobilon
p
transfer
membran
millipor
bedford
block
milk
solut
tb
least
hr
primari
antibodi
commerci
avail
antiegf
calbiochem
san
diego
ca
use
ratio
bsatb
buffer
overnight
room
temperatur
wash
min
tb
buffer
blot
incub
ratio
tb
secondari
antibodi
antirabbit
igg
fabspecif
alkalin
phosphatas
conjug
sigma
st
loui
mo
wash
presenc
egf
protein
detect
use
color
substrat
bcipnbt
final
concentr
wv
phosphat
wv
nitro
blue
tetrazolium
vv
dementhylformadmid
kpl
gaithersburg
total
solubl
protein
extract
dri
soybean
seed
describ
previous
line
pgli
shegf
transgen
plant
along
nontransgen
seed
neg
control
egf
quantit
commerci
avail
human
egf
elisa
assay
quantikin
elisa
kit
r
system
minneapoli
mn
accord
manufactur
instruct
provid
posit
control
use
creat
standard
curv
order
determin
amount
egf
soybean
protein
extract
homozygot
egf
transgen
line
assay
three
biolog
replic
result
display
mean
standard
error
total
solubl
protein
extract
quantit
suspend
sampl
load
buffer
previous
describ
approxim
protein
extract
dri
seed
homozyg
egf
line
separ
gradient
sdspage
gel
biorad
hercul
ca
along
extract
nontransgen
seed
gel
subsequ
stain
wv
coomassi
brilliant
blue
vv
methanol
vv
acet
acid
overnight
destain
approxim
hr
methanol
acet
acid
frequent
solut
chang
total
solubl
protein
extract
biolog
egf
transgen
soybean
dri
seed
sampl
line
describ
protein
molecular
weight
lower
kda
concentr
use
amicon
ultra
centrifug
filter
merck
kenilworth
nj
nontransgen
seed
use
neg
control
commerci
avail
egf
immunoblot
section
posit
control
protein
precipit
adjust
solut
vv
trichloroacet
acid
allow
sit
overnight
precipit
protein
pellet
use
centrifug
wash
twice
aceton
dri
use
vacuum
centrifug
commerci
egf
filter
precipit
dri
dri
pellet
rehydr
addit
mm
dithiothreitol
mm
ammonium
bicarbon
place
minut
reduc
disulphid
bond
sampl
alkyl
addit
iodacetamid
mm
ammonium
bromid
place
room
temperatur
dark
minut
two
trypsin
mm
ammonium
bromid
ad
sampl
place
overnight
enzymat
digest
post
trypsin
digest
sampl
desalt
use
peptid
revers
phase
microtrap
michrom
bioresourc
auburn
ca
dri
ultim
resuspend
vv
acetonitril
vv
formic
acid
separ
peptid
perform
use
dionex
splitless
nanoflow
hplc
system
oper
nl
minut
use
gradient
acetonitril
minut
follow
minut
wash
acetonitril
minut
equilibr
acetonitril
column
inhous
prepar
cm
revers
phase
column
pack
halo
materi
macmod
analyt
chadd
ford
pa
locat
ion
sourc
silica
emitt
potenti
volt
appli
use
liquid
junction
column
emitt
thermo
ltq
velo
pro
mass
spectromet
use
nanospray
flex
ion
sourc
use
analyz
eluat
scan
paramet
ltq
velo
pro
one
ms
scan
follow
msm
scan
intens
peak
msm
scan
perform
pair
cid
fragment
scan
follow
hcd
fragment
scan
precursor
mz
dynam
exclus
enabl
mass
exclus
time
min
repeat
count
within
sec
initi
mz
measur
spectra
collect
entireti
minut
chromatographi
run
raw
mass
spectra
convert
mgf
format
use
msconvert
part
proteowizard
softwar
librari
x
tandem
omssa
algorithm
employ
via
univers
arizona
high
perform
comput
center
perform
spectrum
match
precursor
fragment
mass
toler
set
dalton
omssa
x
tandem
trypsin
cleavag
rule
use
algorithm
miss
cleavag
amino
acid
modif
search
consist
singl
doubl
oxid
methionin
oxid
prolin
ntermin
acetyl
carbamidomethyl
cystein
deamid
asparagin
glutamin
phosphoryl
serin
threonin
tyrosin
x
tandem
xml
omssa
xml
result
filter
use
perl
remov
peptid
match
evalu
well
protein
identifi
singl
peptid
sequenc
protein
fasta
databas
glycin
max
download
august
ncbi
refseq
addit
egf
amino
acid
sequenc
random
version
glycin
max
fasta
concaten
origin
way
assess
dataset
qualiti
mass
spectrometri
proteom
data
deposit
proteomexchang
constortium
http
proteomecentralproteomexchangeorg
via
pride
partner
repositori
dataset
identifi
hela
cell
obtain
american
tissu
cultur
collect
cultur
minimum
essenti
media
mem
complement
fetal
bovin
serum
fb
unitsml
penicillin
streptomycin
western
blot
assay
cell
grown
plate
kept
serum
free
mem
media
hour
cell
either
kept
serum
free
medium
control
stimul
soy
milk
alon
soy
egf
commerci
recombin
human
egf
differ
time
period
indic
cell
lyse
directli
ad
sd
sampl
buffer
mm
ph
glycerol
sd
cell
wash
time
pb
egf
bioactiv
determin
via
egfr
phosphoryl
downstream
akt
phosphoryl
total
egfr
also
measur
sinc
egfr
known
undergo
intern
stimul
egf
antibodi
use
western
blot
antipegfr
cell
signal
technolog
antitot
egfr
millipor
antipakt
cell
signal
technolog
antilamin
cell
signal
technolog
immunocytochemistri
assay
cell
grown
coverslip
plate
kept
serum
free
media
hour
stimul
cell
either
kept
serum
free
media
control
stimul
human
soy
egf
hour
cell
wash
pb
fix
formalin
egfr
label
use
antiegfr
antibodi
cell
signal
technolog
detect
alexa
fluor
goat
antirabbit
igg
life
technolog
cell
nucleu
shown
use
mount
medium
dapi
vectorshield
produc
hegf
soybean
strong
soybean
seedspecif
promot
termin
use
regul
gene
express
synthet
soybean
codon
optim
hegf
shegf
gene
includ
ntermin
nucleotid
ersign
sequenc
fig
engin
strategi
hegf
express
soybean
compon
prepro
portion
hegf
elimin
prefer
produc
final
recombin
hegf
product
facilit
cotransl
transfer
egf
er
lumen
disulfid
bond
format
plant
signal
sequenc
ad
hegf
synthes
would
prehegf
gli
shegf
construct
use
biolist
transform
soybean
somat
embryo
cell
outlin
embryo
select
liquid
cultur
hygromycin
b
individu
regener
line
separ
propag
induc
form
cotyledonari
embryo
cotyledonari
embryo
evalu
hegf
product
use
egfspecif
elisa
indic
variat
heterolog
protein
product
data
shown
promis
egf
express
line
move
forward
regener
desicc
subsequ
germin
initi
gener
egf
transgen
plant
grown
greenhous
select
genom
pcr
addit
gener
addit
gener
seed
produc
select
line
assay
hegf
content
elisa
hegf
content
line
seed
repres
homozyg
popul
shown
fig
line
vari
hegf
content
seed
within
line
narrow
rang
hegf
accumul
egf
transgen
line
produc
excess
hegf
per
gm
dri
seed
weight
level
calcul
much
excess
potenti
therapeut
requir
comparison
yeast
stain
use
express
system
human
egf
mous
egf
highest
level
produc
multicopi
insert
pichia
pastori
clone
secret
egfml
mous
human
egf
yeast
product
system
truncat
version
egf
detect
hegf
soybean
nontransgen
soybean
evalu
determin
biochem
authent
soybeanproduc
egf
protein
use
sdspage
parallel
immunoblot
probe
antiegf
solubl
low
molecular
weight
kda
seed
protein
mr
soybeanproduc
hegf
evalu
total
protein
polypeptid
hegf
express
line
appear
ident
standard
parent
control
fig
immunoblot
sdspage
probe
antiegf
show
lack
immunoreact
band
nontransgen
soybean
seed
control
recogn
kda
mr
band
hegf
express
line
soybeanproduc
hegf
appar
mr
authent
recombin
hegf
fraction
adjac
lane
fig
assess
soybeansynthes
hegf
seed
lysat
enrich
low
mr
total
protein
concentr
crude
low
mr
protein
reduc
alkyl
cleav
trypsin
prior
analysi
mass
spectrometri
result
data
queri
hegf
sequenc
exact
match
peptid
encompass
major
sequenc
complet
matur
hegf
protein
obtain
fig
togeth
data
show
transgen
soybean
success
produc
accumul
hegf
correct
mr
immunoreact
antibodi
direct
authent
egf
elisa
immunoblot
assay
major
mass
spectrometri
fragment
soybeanproduc
hegf
match
human
egf
sequenc
deliveri
biopharma
product
context
composit
complex
food
present
potenti
compon
food
may
act
modul
bioactiv
plantsourc
food
particular
pose
problem
plant
tissu
often
possess
wide
rang
intrins
biolog
activ
compon
includ
protein
natur
product
natur
product
food
could
mask
enhanc
effect
express
biopharma
product
evalu
potenti
egf
activ
soymilk
deliveri
commerci
recombin
human
egf
rhegf
ad
supplement
soymilk
intrins
activ
egf
test
hela
cell
assay
fig
show
effect
soymilk
display
egf
receptor
egfr
hela
cell
effect
commerci
rhegf
supplement
soymilk
soymilk
modifi
display
egfr
hela
cell
show
soymilk
alon
biolog
inact
bind
egf
egfr
result
decreas
display
egfr
intern
hela
cell
hela
cell
treat
commerci
avail
recombin
rhegfsuppl
soymilk
display
decreas
egfr
cell
treat
rhegf
media
without
soymilk
parallel
timecours
experi
show
effect
rhegf
bind
efgr
rapid
reduct
display
efgr
occur
within
min
treatment
continu
least
min
data
shown
togeth
assay
show
soymilk
appar
neg
bioactiv
respect
bind
commerci
rhegf
hela
cell
egfr
viabil
hela
cell
cours
assay
assess
bioactiv
soybeanproduc
hegf
sampl
prepar
shegf
transgen
soybean
line
nontransgen
control
use
stimul
hela
cell
induc
egfr
intern
degrad
phosphoryl
result
shown
fig
soybeanproduc
hegf
induc
intern
degrad
phosphoryl
egfr
indistinguish
bioactiv
commerci
rhegf
deliv
control
sampl
contrast
sampl
prepar
control
nontransgen
soybean
exhibit
appar
bioactiv
show
degrad
phosphoryl
egfr
result
egf
bind
either
commerci
rhegf
ad
media
hegf
produc
transgen
soybean
togeth
result
show
nontransgen
soybean
seed
intrins
egfmim
activ
abl
induc
egfr
degrad
phosphoryl
soybean
produc
hegf
ident
activ
comparison
commerci
rhegf
develop
foodbas
deliveri
platform
biopharma
import
address
question
whether
signific
collater
consequ
seed
composit
result
genet
modif
ideal
consumpt
plant
biotechnolog
platform
soymilk
fulli
equival
standard
type
intend
modif
seed
gener
includ
soybean
possess
inventori
bioactiv
protein
small
molecul
affect
metabol
consum
advantag
disadvantag
manner
soybean
relev
molecul
allergen
antimetabolit
protein
small
molecul
especi
isoflavon
test
potenti
collater
composit
hegfproduc
soybean
shegf
transgen
nontransgen
control
soybean
analyz
nontarget
proteom
metabolom
among
signific
protein
identifi
includ
variou
welldocu
allergen
antimetabolit
protein
comparison
standard
soybean
hegfproduc
soybean
line
show
signific
differ
p
nontransgen
control
shegf
transgen
soybean
asid
target
product
hegf
protein
concern
data
avail
pride
partner
repositori
dataset
identifi
nontarget
small
molecul
metabolom
use
conduct
parallel
analysi
nontransgen
hegf
soybean
insignific
differ
nontransgen
soybean
seed
shegf
transgen
seed
fig
one
notabl
except
soybean
highli
regul
sulfur
avail
alloc
protein
nutrit
perspect
soybean
consid
somewhat
sulfur
defici
crop
number
biotechnolog
experi
increas
sulfur
content
either
modifi
assimil
biosynthesi
pathway
lead
methionin
overexpress
highmethionin
protein
maiz
zein
modifi
sulfur
pathway
competit
effect
sulfurrespons
protein
includ
bowmanbirk
trypsin
inhibitor
bbi
beta
chain
storag
protein
conglycinin
egf
high
sulfur
content
protein
broadli
mimic
bbi
small
globular
protein
synthes
er
presumpt
compet
sulfur
amino
acid
charg
trna
express
hegf
soybean
effect
metabolit
involv
sulfur
amino
acid
metabol
consist
produc
protein
egf
composit
complet
dataset
metabolit
abund
standard
hegfexpress
line
avail
onlin
spreadsheet
tabl
among
assay
molecul
particular
note
soybean
molecul
genistein
isoflavon
shown
affect
activ
tyrosin
phosphatas
signal
cascad
associ
egf
signal
genistein
level
determin
nontransgen
hegfexpress
soybean
line
demonstr
express
hegf
soybean
produc
incident
collater
consequ
concern
potenti
therapeut
use
sinc
incept
plant
biotechnolog
potenti
use
biopharma
applic
assess
sever
differ
plant
organ
propos
product
foodfe
deliveri
system
mani
vaccin
applic
fruit
highli
advantag
deliveri
system
provid
broadli
accept
platform
even
recalcitr
consum
exampl
although
fruit
perhap
one
best
deliveri
system
perspect
point
deliveri
fruit
also
logist
issu
rel
short
time
ripen
fruit
palat
requir
tightli
coordin
effort
produc
distribut
use
biopharma
product
could
challeng
deploy
mass
quantiti
altern
develop
biopharma
platform
broadli
accept
food
feed
deliveri
lightli
process
preserv
bioactiv
massiv
scale
maxim
distribut
potenti
product
soybean
potenti
use
biopharma
platform
could
broad
applic
food
feed
end
use
soybean
demonstr
platform
produc
heterolog
protein
standard
far
exce
level
typic
need
biopharma
soybean
use
produc
soymilk
formula
potenti
deliveri
human
infant
children
well
product
anim
swine
calv
soybean
also
use
produc
protein
concentr
inclus
industri
food
feed
simpli
protein
aggreg
tofu
soybean
product
effici
econom
massiv
scale
need
recent
develop
technolog
make
feasibl
increas
amount
recombin
protein
product
silenc
exchang
storag
protein
platform
soybean
industri
crop
vast
major
total
product
direct
toward
product
includ
process
food
protein
use
anim
feed
oil
food
feed
fuel
chemic
feedstock
use
mani
goal
enhanc
modifi
soybean
larg
direct
improv
util
industri
product
rather
direct
food
use
biopharma
platform
produc
soymilk
deriv
product
soybean
seed
store
year
anticip
futur
need
retain
potenti
rapidli
process
formulamilk
tofu
use
adapt
tradit
technolog
use
millennium
soybean
like
mani
seed
produc
array
intrins
small
globular
protein
secondari
disulfid
bond
accumul
rel
high
level
total
protein
soybean
particular
accumul
bowmanbirk
trypsin
inhibitor
kda
intrachain
disulfid
bond
suggest
soybean
seed
optim
potenti
bioreactor
produc
store
protein
like
egf
kda
protein
intra
chain
disulfid
bond
parallel
intrins
seed
protein
predecessor
experi
mutant
inact
bbi
express
transgen
soybean
show
altern
small
protein
express
soybean
express
construct
encod
shegf
regul
soybean
seed
storag
protein
promot
result
accumul
hegf
gm
dri
soybean
seed
level
mani
fold
estim
therapeut
requir
weight
treat
individu
soybeanproduc
hegf
appear
complet
compar
authent
hegf
mr
immunoreact
specif
antibodi
correspond
fragment
sequenc
mass
spectrometri
assay
bioactiv
induc
intern
degrad
phosphoryl
efgr
togeth
result
shown
demonstr
soybean
seed
produc
hegf
prototherapeut
level
deriv
hegf
seed
bioactiv
egf
activ
model
hela
cell
assay
soybean
use
express
platform
wide
varieti
heterolog
protein
investig
well
potenti
foodfe
biopharma
goal
prior
biopharma
express
includ
prototyp
express
vaccin
model
well
proinsulin
fibroblast
human
growth
factor
studi
potenti
collater
chang
prototyp
product
matur
soybean
seed
result
hegf
express
evalu
nontarget
proteom
metabolom
assess
larg
small
molecul
assess
show
signific
differ
seed
proteom
egf
transgen
compar
nontransgen
pertin
result
soybean
regul
us
falpa
food
allergen
label
protect
act
unintend
alter
known
seed
allergen
antinutrit
protein
concern
similarli
nontarget
metabolom
soybean
seed
show
signific
lack
alter
small
molecul
profil
respons
hegf
accumul
among
molecul
assess
lack
chang
genistein
among
signific
isoflavonoid
shown
activ
tyrosin
phosphatas
signal
cascad
anim
human
cell
includ
egfegfr
signal
hela
cell
assess
synergist
effect
standard
soybean
milk
authent
egf
egfr
activ
indic
ident
genistein
concentr
standard
hegf
express
soybean
threshold
effect
assay
conduct
one
signific
alter
small
molecul
profil
methioninerel
metabol
egf
sulfur
rich
protein
contain
three
disulfid
bond
gener
resembl
soybean
bowmanbirk
inhibitor
soybean
rel
sulfur
defici
crop
much
effort
made
increas
sulfur
amino
acid
content
either
coexpress
sulfurrich
protein
zein
increas
sulfur
flux
alter
sulfur
amino
acid
pathway
studi
shown
within
limit
increas
sulfur
sink
express
highsulfur
content
protein
collater
induc
modest
increas
sulfur
amino
acid
sourc
result
increas
sulfur
amino
acid
metabolit
accompani
hegf
express
soybean
accord
prior
experi
togeth
result
nontarget
proteom
metabolom
assess
show
convert
soybean
prototyp
biopharma
deliveri
platform
hegf
result
advers
alter
soybean
seed
composit
soybean
could
use
produc
biopharma
product
might
deliv
milk
formula
test
concept
human
epiderm
growth
factor
hegf
produc
soybean
potenti
address
devast
diseas
neonat
necrot
enterocol
diseas
prematur
infant
low
birth
weight
infant
underdevelop
organ
includ
intestin
tract
result
gangren
infect
treat
emerg
surgeri
remov
dead
portion
intestin
tract
even
optimist
situat
high
mortal
rate
high
cost
treatment
altern
approach
proactiv
treat
infant
risk
immedi
postpartum
attempt
improv
integr
matur
line
epitheli
cell
bioactiv
result
model
hela
cell
show
hegf
produc
accumul
soybean
seed
crude
soymilk
lysat
capabl
stimul
respons
egf
receptor
egfr
occur
epiderm
surfac
intestin
tract
soybeanproduc
hegf
potenti
applic
cosmet
burn
injuri
treatment
stimul
improv
adapt
bowel
massiv
intestin
loss
